COMMUNIQUÉS West-GlobeNewswire

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board
28/05/2026
As of May 27, 2026, Enlivex held 79,568,550,005 RAIN tokens with a total value of approximately $1.16 billion. Separately, the Rain Foundation recently announced the appointment of five industry leaders to its advisory [...]
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
28/05/2026
Auto-renewing Master Services Agreement engages Biomerica’s integrated development and manufacturing platform, reflecting the Company’s CDMO strategy as a capital-efficient, parallel revenue stream alongside its core [...]
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference
28/05/2026
EMERYVILLE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic [...]
Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that [...]
10X Health Launches New Supplements to Address Mobility & Circulation
28/05/2026
Rooted in science and clinically studied, 10X MoveEase™ and 10X Blood Flow Support™ are designed to improve overall daily performance and function SCOTTSDALE, Ariz., May 28, 2026 (GLOBE NEWSWIRE) -- 10X Health , a [...]
Prime Medicine to Present at Jefferies Global Healthcare Conference
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced [...]
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
28/05/2026
ZUG, Switzerland and BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team are scheduled to participate in the following investor [...]
World Trade Center Health Program Launches National Awareness Initiative to Reach Those Who Were Impacted by 9/11 as Children or Teens
28/05/2026
New outreach initiative features New York City sketch artist and influencer Devon Rodriguez to reach individuals impacted by 9/11 at an early age and help them understand they may be eligible for no-cost medical [...]
Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
28/05/2026
MENLO PARK, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment [...]
Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates
28/05/2026
Sol-Gel received a Notice of Allowance for a method-of-use patent extending intellectual property protection for topical patidegib (SGT-610) until 2044 Sol-Gel completed an oversubscribed underwritten offering, raising [...]
Jushi Holdings Inc. Announces Applications Submitted for DEA Registration of State-Licensed Medical Cannabis Operations
28/05/2026
BOCA RATON, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ) , a vertically integrated, multi-state cannabis operator, today announced that it has [...]
Thousands of people march to protest Ford’s hospital privatization, Demand he return that funding to our public hospitals
28/05/2026
TORONTO, May 28, 2026 (GLOBE NEWSWIRE) -- They are coming from towns across the province, where their local hospitals have been pushed into deficit and forced by the Ford government to make cuts. They are coming in the [...]
Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST
28/05/2026
NDA acceptance with Priority Review builds upon previous assignment of Breakthrough Therapy Designation and Real-Time Oncology Review following Phase 3 PEAK results; PDUFA date set for November 30, 2026 Bezuclastinib [...]
SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum
28/05/2026
TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation
28/05/2026
TEL AVIV, May 28, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that multiple abstracts across its oral peptide [...]
FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY
28/05/2026
WEST PALM BEACH, FL and MINNETONKA, MN, May 28, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the “Company”) and LongevityFP Technologies, LLC. (“LFP”) today jointly announced a strategic partnership to [...]
Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
28/05/2026
SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with [...]
Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
28/05/2026
VANCOUVER, British Columbia, May 28, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights
28/05/2026
- Achieves U.S. FDA 510(k) Clearance for Next-Generation Hybrid IVUS-OCT Imaging System - Wins Multiple Industry Awards Recognizing Innovation and Leadership in Intravascular Imaging - Advances U.S. Commercial Readiness [...]

Pages